Allarity Therapeutics, Inc. Share-based Payment Arrangement, Expense
Allarity Therapeutics, Inc. (ALLR) reported Share-based Payment Arrangement, Expense of $188.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $188.00K, a 14.63% increase year-over-year.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $132.00K, a 676.47% increase year-over-year.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-06-30 was $164.00K, a 645.45% increase year-over-year.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for the quarter ending 2025-03-31 was $139.00K.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2022 was $1.15M, a 41.35% increase from fiscal 2021.
- Allarity Therapeutics, Inc. share-based payment arrangement, expense for fiscal 2021 was $815.00K.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $188.00K 10-Q · filed 2026-08-14 | $348.00K 10-Q · filed 2026-08-14 | ||||
| 2025-09-30 | $132.00K 10-Q · filed 2025-11-14 | $296.00K derived: sum of 2 quarters · filed 2026-08-14 | $435.00K 10-Q · filed 2025-11-14 | |||
| 2025-06-30 | $164.00K 10-Q · filed 2026-08-14 | $303.00K 10-Q · filed 2026-08-14 | ||||
| 2025-03-31 | $139.00K 10-Q · filed 2025-05-09 | |||||
| 2024-09-30 | $17.00K 10-Q · filed 2025-11-14 | $39.00K derived: sum of 2 quarters · filed 2025-11-14 | $7.00K 10-Q · filed 2025-11-14 | |||
| 2024-06-30 | $22.00K 10-Q · filed 2025-08-15 | -$22.00K 10-Q · filed 2024-08-05 | -$10.00K 10-Q · filed 2025-08-15 | $10.00K 10-Q · filed 2024-08-05 | ||
| 2024-03-31 | -$32.00K 10-Q · filed 2025-05-09 | $32.00K 10-Q · filed 2024-05-14 | ||||
| 2023-09-30 | $180.00K 10-Q · filed 2024-11-14 | $360.00K derived: sum of 2 quarters · filed 2024-11-14 | $59.00K 10-Q · filed 2024-11-14 | |||
| 2023-06-30 | $180.00K 10-Q · filed 2024-08-05 | $59.00K 10-Q · filed 2024-08-05 | ||||
| 2022-12-31 | $1.15M 10-K · filed 2023-03-13 | |||||
| 2021-12-31 | $815.00K 10-K · filed 2023-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |